Live from the NIH registry
Studies recruiting near Victorville right now
Top 25 of 56 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Crystalys Therapeutics
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Om Research LLC — Victorville, California (3.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Victorville, California (3.6 mi)
· Sponsor: AstraZeneca
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Psoriatic Arthritis, Axial Spondyloarthritis
Phase 1
Interventional 392 participants sought
Pa0019 127 — Apple Valley, California (9.7 mi)
· Sponsor: UCB Biopharma SRL
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Kidney Disease, Peritoneal Dialysis (PD)
N/A
Observational 125 participants sought
Desert Cities Dialysis — Victorville, California (3.6 mi)
· Sponsor: Bodyport Inc.
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Central Line Associated Blood Stream Infections (CLABSI)
N/A
Interventional 17,800 participants sought
St. Mary Medical Center — Apple Valley, California (9.7 mi)
· Sponsor: Swedish Medical Center
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
National Institute of Clinical Research - Victorville — Victorville, California (3.6 mi)
· Sponsor: Boehringer Ingelheim
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 671 participants sought
Om Research, LLC - Victorville - Site Number: 8400022 — Victorville, California (3.6 mi)
· Sponsor: Sanofi
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Site US10008 — San Bernardino, California (29.2 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Inland Empire Clinical Trials, LLC — Rialto, California (29.1 mi)
· Sponsor: Boehringer Ingelheim
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
Moderate Hepatic Impairment
Phase 1
Interventional 20 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Non-small Cell Lung Cancer, Melanoma
Phase 1
Interventional 174 participants sought
Oncology Physicians Network (OPN) - San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Shanghai Henlius Biotech
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Velocity Clinical Research- Banning — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Inland Empire Liver Foundation — Rialto, California (29.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Rialto, California (29.1 mi)
· Sponsor: 89bio, Inc.
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
National Institute of Clinical Research, Inc. — Victorville, California (3.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
Phase 3
Interventional 900 participants sought
Research Site — Victorville, California (3.6 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Apple Valley, California (9.7 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Calliditas Therapeutics AB
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart Failure, Left Ventricular Systolic Dysfunction
Phase 2, Phase 3
Interventional 342 participants sought
Loma Linda University Health System ( Site 0008) — San Bernardino, California (29.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Om Research LLC — Victorville, California (3.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridioides Difficile Associated Disease
Phase 3
Interventional 32,000 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Influenza
Phase 3
Interventional 4,000 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: ModernaTX, Inc.
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Hepatic Impairment
Phase 1
Interventional 28 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca